Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular disease (CVD) is a primary concern for patients with end-stage renal disease (ESRD), particularly those on hemodialysis.
• ESRD patients often exhibit atypical or absent symptoms of coronary artery disease (CAD).
• Coronary lesions in ESRD are pathologically distinct, featuring thickened media, macrophage infiltration, and calcification.

Purpose of the Study:

• To highlight the challenges in managing cardiovascular disease in ESRD patients.
• To underscore the suboptimal outcomes of current cardiovascular interventions in this population.
• To advocate for modified diagnostic, preventive, and management strategies for CVD in ESRD.

Main Methods:

• Review of existing literature on cardiovascular disease in ESRD.
• Analysis of clinical outcomes following coronary revascularization in ESRD patients.
• Evaluation of the efficacy of cardiovascular medications and interventions in ESRD.

Main Results:

• Clinical outcomes after coronary revascularization are poorer in ESRD patients, correlating with renal dysfunction severity.
• Hemodialysis patients experience the worst outcomes due to severe renal impairment.
• Standard cardiovascular preventive medications and drug-eluting stents demonstrate reduced efficacy in ESRD.

Conclusions:

• Current approaches to cardiovascular disease in ESRD are insufficient.
• There is a significant unmet need for improved strategies in diagnosing, preventing, and managing CVD in ESRD patients.
• Tailored interventions are crucial to enhance cardiovascular health and clinical outcomes in this vulnerable population.